MD, W., S, Z., XY, L., PP, W., YF, Z., JR, Z., . . . L, W. (2023). Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation. Acta pharmacologica Sinica, 44(11), 2151. https://doi.org/10.1038/s41401-023-01125-3
Chicago Style (17th ed.) CitationMD, Wang, et al. "Salvianolic Acid B Ameliorates Retinal Deficits in an Early-stage Alzheimer's Disease Mouse Model Through Downregulating BACE1 and Aβ Generation." Acta Pharmacologica Sinica 44, no. 11 (2023): 2151. https://doi.org/10.1038/s41401-023-01125-3.
MLA (9th ed.) CitationMD, Wang, et al. "Salvianolic Acid B Ameliorates Retinal Deficits in an Early-stage Alzheimer's Disease Mouse Model Through Downregulating BACE1 and Aβ Generation." Acta Pharmacologica Sinica, vol. 44, no. 11, 2023, p. 2151, https://doi.org/10.1038/s41401-023-01125-3.